Kalaris Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $277.1M
Liabilities Breakdown FY2022
Total Liabilities: $52.6M
Asset Breakdown
Total Assets: $277.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $106.1M | 38.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $930.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $170.1M | 61.4% |
Liabilities Breakdown
Total Liabilities: $52.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 5.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $49.6M | 94.3% |